Paper3125883
Secondary prevention of vascular disease by prolonged antiplatelet treatment. Antiplatelet Trialists' Collaboration.
Br Med J (Clin Res Ed), 1988. Cited by 132 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Secondary prevention of vascular disease by prolonged antiplatelet treatment. Antiplatelet Trialists' Collaboration. Papers, record 3125883. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3125883
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Secondary prevention of vascular disease by prolonged antiplatelet treatment. Antiplatelet Trialists' Collaboration.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Angina Pectoris | Major topic |
| Angina, Unstable | Major topic |
| Cerebrovascular Disorders | Major topic |
| Myocardial Infarction | Major topic |
| Platelet Aggregation Inhibitors | Major topic |
| Aspirin | |
| Dipyridamole | |
| Drug Combinations | |
| Humans | |
| Prognosis | |
| Random Allocation | |
| Sulfinpyrazone |
Source PubMed
References32
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4,885,615 | Controlled trial of dipyridamole in cerebral vascular disease. | Br Med J | 1969 | https://conductscience.org/library/papers/4885615 | PubMed |
| 2 | 3,317,048 | Current medical and surgical therapy for cerebrovascular disease. | N Engl J Med | 1987 | https://conductscience.org/library/papers/3317048 | PubMed |
| 3 | 1,105,880 | Proceedings: The effect of a platelet inhibiting drug (sulfinpyrazone) in the therapy of patients with transient ischemic attacks (Tia's) and minor strokes. | Thromb Diath Haemorrh | 1975 | https://conductscience.org/library/papers/1105880 | PubMed |
| 4 | 324,036 | Controlled trial of aspirin in cerebral ischemia. | Stroke | 1977 | https://conductscience.org/library/papers/324036 | PubMed |
| 5 | 354,098 | Controlled trial of aspirin in cerebral ischemia. Part II: surgical group. | Stroke | 1978 | https://conductscience.org/library/papers/354098 | PubMed |
| 6 | 92,668 | Aspirin and secondary mortality after myocardial infarction. | Lancet | 1979 | https://conductscience.org/library/papers/92668 | PubMed |
| 7 | 7,005,035 | Secondary prevention of myocardial infarction: a comparison of acetylsalicylic acid, placebo and phenprocoumon. | Haemostasis | 1980 | https://conductscience.org/library/papers/7005035 | PubMed |
| 8 | 7,027,408 | ["A.I.C.L.A." controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia. Part I: Protocol (author's transl)]. | Rev Neurol (Paris) | 1981 | https://conductscience.org/library/papers/7027408 | PubMed |
| 9 | 7,039,004 | A randomized trial of aspirin and sulfinpyrazone in patients with TIA. | Stroke | 1982 | https://conductscience.org/library/papers/7039004 | PubMed |
| 10 | 6,815,756 | [Prevention of recurrences of cerebral ischemic vascular accidents by platelet antiaggregants. Results of a 3-year controlled therapeutic trial]. | Rev Neurol (Paris) | 1982 | https://conductscience.org/library/papers/6815756 | PubMed |
| 11 | 6,337,425 | Acetylsalicylic acid in the prevention of stroke in patients with reversible cerebral ischemic attacks. A Danish cooperative study. | Stroke | 1983 | https://conductscience.org/library/papers/6337425 | PubMed |
| 12 | 6,401,878 | "AICLA" controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia. | Stroke | 1983 | https://conductscience.org/library/papers/6401878 | PubMed |
| 13 | 6,345,461 | Aspirin in coronary heart disease. Comparison of six clinical trials. | Isr J Med Sci | 1983 | https://conductscience.org/library/papers/6345461 | PubMed |
| 14 | 6,367,153 | Prolongation of bleeding time and inhibition of platelet aggregation by low-dose acetylsalicylic acid in patients with cerebrovascular disease. | Stroke | 1984 | https://conductscience.org/library/papers/6367153 | PubMed |
| 15 | 6,144,975 | Improved aortocoronary bypass patency by low-dose aspirin (100 mg daily). Effects on platelet aggregation and thromboxane formation. | Lancet | 1984 | https://conductscience.org/library/papers/6144975 | PubMed |
| 16 | 6,745,127 | Aspirin in the prevention of myocardial infarction. Current status. | Drugs | 1984 | https://conductscience.org/library/papers/6745127 | PubMed |
| 17 | 6,385,651 | The North American ticlopidine aspirin stroke study: structure, stratification variables, and patient characteristics. | Agents Actions Suppl | 1984 | https://conductscience.org/library/papers/6385651 | PubMed |
| 18 | 6,385,653 | Canadian American ticlopidine study (cats) in thromboembolic stroke. | Agents Actions Suppl | 1984 | https://conductscience.org/library/papers/6385653 | PubMed |
| 19 | 2,858,114 | Beta blockade during and after myocardial infarction: an overview of the randomized trials. | Prog Cardiovasc Dis | 1985 | https://conductscience.org/library/papers/2858114 | PubMed |
| 20 | 2,988,158 | A secondary prevention, randomized trial of suloctidil in patients with a recent history of thromboembolic stroke. | Stroke | 1985 | https://conductscience.org/library/papers/2988158 | PubMed |
Cited by112
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 132 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,774,848 | [Anatomy of the Forest Plot graphic]. | Rev Med Inst Mex Seguro Soc | 2026 | https://conductscience.org/library/papers/41774848 | PubMed |
| 41,702,715 | Research Waste, Redundancy and the Rise of the Machines: The Questionable Future of Systematic Reviews. | Drug Alcohol Rev | 2026 | https://conductscience.org/library/papers/41702715 | PubMed |
| 40,910,165 | Health Status Outcomes With Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting in ISCHEMIA. | Circulation | 2025 | https://conductscience.org/library/papers/40910165 | PubMed |
| 40,769,693 | Oral Anticoagulant Management for Peripheral Vascular Disease. | Adv Surg | 2025 | https://conductscience.org/library/papers/40769693 | PubMed |
| 40,491,717 | Methods and validity indicators for measuring adherence and persistence to aspirin in secondary cardiovascular prevention: a systematic review. | Front Cardiovasc Med | 2025 | https://conductscience.org/library/papers/40491717 | PubMed |
| 39,763,632 | Role of aspirin in the primary prevention of cardiovascular disease in patients with hyperlipoproteinaemia(a). | Drugs Context | 2024 | https://conductscience.org/library/papers/39763632 | PubMed |
| 39,064,188 | Aspirin in Primary Prevention: Looking for Those Who Enjoy It. | J Clin Med | 2024 | https://conductscience.org/library/papers/39064188 | PubMed |
| 38,791,515 | Initial Despair and Current Hope of Identifying a Clinically Useful Treatment of Myocardial Reperfusion Injury: Insights Derived from Studies of Platelet P2Y12 Antagonists and Interference with Inflammation and NLRP3 Assembly. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38791515 | PubMed |
| 38,784,152 | Controversy in cardiology: clopidogrel or acetylsalicylic acid in the treatment of chronic coronary syndromes? | Eur Heart J Suppl | 2024 | https://conductscience.org/library/papers/38784152 | PubMed |
| 37,622,482 | Ischaemic stroke despite antiplatelet therapy: Causes and outcomes. | Eur Stroke J | 2023 | https://conductscience.org/library/papers/37622482 | PubMed |
| 34,824,680 | Aspirin in the Modern Era of Cardiovascular Disease Prevention. | Methodist Debakey Cardiovasc J | 2021 | https://conductscience.org/library/papers/34824680 | PubMed |
| 30,773,981 | Reflections on the design and analysis of clinical trials and meta-analyses in the 1970s and 1980s. | J R Soc Med | 2019 | https://conductscience.org/library/papers/30773981 | PubMed |
| 30,505,394 | Effect of Sociodemographic Variables and Other Factors on the Usage of Different Doses of Aspirin in Postmyocardial Infarction Patients: A Cross-sectional Study. | Heart Views | 2018 | https://conductscience.org/library/papers/30505394 | PubMed |
| 30,368,251 | Partially systematic thoughts on the history of systematic reviews. | Syst Rev | 2018 | https://conductscience.org/library/papers/30368251 | PubMed |
| 29,236,147 | [Platelet inhibition in elderly patients]. | Herz | 2018 | https://conductscience.org/library/papers/29236147 | PubMed |
| 28,403,216 | Efficacy and safety of aspirin in patients with peripheral vascular disease: An updated systematic review and meta-analysis of randomized controlled trials. | PLoS One | 2017 | https://conductscience.org/library/papers/28403216 | PubMed |
| 28,360,907 | Aspirin: The Mechanism of Action Revisited in the Context of Pregnancy Complications. | Front Immunol | 2017 | https://conductscience.org/library/papers/28360907 | PubMed |
| 27,482,236 | Changes in pre-hospital management of vascular risk factors among patients admitted due to recurrent stroke in Poland from 1995 to 2013. | Arch Med Sci | 2016 | https://conductscience.org/library/papers/27482236 | PubMed |
| 27,423,939 | The ADAPTABLE Trial and Aspirin Dosing in Secondary Prevention for Patients with Coronary Artery Disease. | Curr Cardiol Rep | 2016 | https://conductscience.org/library/papers/27423939 | PubMed |
| 27,059,906 | History of evidence synthesis to assess treatment effects: Personal reflections on something that is very much alive. | J R Soc Med | 2016 | https://conductscience.org/library/papers/27059906 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Authors
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3125883
GET https://conductscience.org/api/papers/v1/3125883/references?page=2